[1]Synthesis,2008,#8,p.1316-1318
[2]BioorganicandMedicinalChemistryLetters,2008,vol.18,#22,p.5926-5931
[3]Tetrahedron,2012,vol.68,#16,p.3336-3341
[1]Patent:US2017/157262,2017,A1,
[1]Juarez-Hernandez,RalE.;Miller,PatriciaA.;Miller,MarvinJ.[ACSMedicinalChemistryLetters,2012,vol.3,#10,p.799-803]
[2]CurrentPatentAssignee:HANGZHOUDACBIOTECHCOLTD-US2017/157262,2017,A1Locationinpatent:Paragraph0206;0207
[3]CurrentPatentAssignee:HANGZHOUDACBIOTECHCOLTD-JP2017/160205,2017,ALocationinpatent:Paragraph0225;0226
[4]CurrentPatentAssignee:HANGZHOUDACBIOTECHCOLTD-US2017/296663,2017,A1Locationinpatent:Paragraph0200;0201
[5]CurrentPatentAssignee:HANGZHOUDACBIOTECHCOLTD-CN110279872,2019,ALocationinpatent:Paragraph0032;0305-0307
Title: Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.